Free public records show SyMap Medical (Suzhou), Ltd. in 2 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by SyMap Medical (Suzhou), Ltd. or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
4 active studies led by SyMap Medical (Suzhou), Ltd., of 4 in all
Source: ClinicalTrials.gov, Studies with SyMap Medical (Suzhou), Ltd. (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies SyMap Medical (Suzhou), Ltd. leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with SyMap Medical (Suzhou), Ltd. or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show SyMap Medical (Suzhou), Ltd.: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets SyMap Medical (Suzhou), Ltd. is in.
Stories on the topics SyMap Medical (Suzhou), Ltd. works in.
Omega-3 supplements are hugely popular. Big trials give mixed answers on whether they protect the heart.
Read
More than 300 million operations are done each year, and many no longer need an overnight stay. Ambulatory…
Read
Cardiovascular disease is the world's leading cause of death, and stroke caused 11.9 million new cases in…
ReadSearch all reports for SyMap Medical (Suzhou), Ltd. All companies